Tag: Real World Data
罕见病管理的“可怕”未来
In a world of rising healthcare costs, the greatest nightmare for payers is reimbursing drug interventions that do not meaningfully benefit their covered lives. Rare disease therapies, often viewed as attractive areas for pharmaceutical & biotech manufacturers, represent some of the most expensive interventions available today given inherently limited competition. Yet, as more manufacturers enter … Continued
Bio-Europe Digital
AMCP Nexus 2021
Three Pathways have emerged in Innovative Access Agreements
The days of simply determining the market demand for a new drug as a function of price and choosing the revenue or profit optimizing point are gone. In our new environment, an explicit rationale, the “value-based price” has become a prerequisite for enabling conversation with payers while policy-makers seem poised to limit the pricing corridors … Continued
Outcomes Based Agreements
The days of simply determining the market demand for a new drug as a function of price and choosing the revenue or profit optimizing point are gone. In our new environment, an explicit rationale, the “value-based price” has become a prerequisite for enabling conversation with payers while policy-makers seem poised to limit the pricing corridors … Continued
Stakeholder perspectives: current and potential benefits
在欧洲的真实世界数据源中,法国医疗保健数据库 SNDS 是最大、也可能是最全面的医疗保健数据资源,覆盖约 6500 万人的生活,超过 99% 的法国人口和约 10% 的欧洲人口。Watch this short video by Nadia Quignot, Director, Decision Analytics & Real World Evidence at … Continued
通过案例研究了解欧洲 HTA 和市场准入的优势和机遇
在欧洲的真实世界数据源中,法国医疗保健数据库 SNDS 是最大、也可能是最全面的医疗保健数据资源,覆盖约 6500 万人的生活,超过 99% 的法国人口和约 10% 的欧洲人口。In this short video by Nadia Quignot, Director, Decision Analytics & Real World Evidence at … Continued
Similarities and differences between SNDS and other claim databases
在欧洲的真实世界数据源中,法国医疗保健数据库 SNDS 是最大、也可能是最全面的医疗保健数据资源,覆盖约 6500 万人的生活,超过 99% 的法国人口和约 10% 的欧洲人口。Watch this short clip by Nadia Quignot, Director, Decision Analytics & Real World Evidence at … Continued
Overview of SNDS and the key working practices to access the database and ongoing SNDS developments
在欧洲的真实世界数据源中,法国医疗保健数据库 SNDS 是最大、也可能是最全面的医疗保健数据资源,覆盖约 6500 万人的生活,超过 99% 的法国人口和约 10% 的欧洲人口。Watch this short video by Nadia Quignot, Director, Decision Analytics & Real World Evidence at … Continued